Capillarographic criteria on the effect of magnesium orotate, EPL substances and clofibrate on the elasticity of blood vessels.
D001161:Arteriosclerosis / Q000188:drug therapy*; D002196:Capillaries / Q000187:drug effects; D002198:Capillary Fragility; D002994:Clofibrate / Q000627:therapeutic use*; D004548:Elasticity; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D009963:Orotic Acid / Q000627:therapeutic use*; D010743:Phospholipids / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects*
D010743:Phospholipids; D009963:Orotic Acid; D002994:Clofibrate; D008274:Magnesium